Catalyst
Slingshot members are tracking this event:
Liquidia's (LQDA) LIQ861 in Pulmonary arterial hypertension PDUFA date due November 7, 2021
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| LQDA | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 08, 2021
Occurred Source:
https://www.liquidia.com/news-releases/news-release-details/fda-grants-tentative-approval-liquidias-yutrepiatm-treprostinil
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Liq861, Pulmonary Arterial Hypertension
